Will Ottawa’s new advisory council on pharmacare amount to “just another study,” or is a national program truly within reach?
Academic rigour, journalistic flair
Articles on Pharmacare
Displaying 21 - 22 of 22 articles
Canada is the only nation with a broad public health system lacking universal coverage for pharmaceuticals. Despite fears that pharmacare would be too costly, it could end up saving Canadians money.
Top contributors
-
Joel Lexchin is a Friend of The Conversation.Professor Emeritus of Health Policy and Management, York University, Canada
-
Associate Professor, Political Science, McMaster University
-
Assistant Professor, Department of Family and Community Medicine, University of Toronto
-
Graduate Student, University of Manitoba
-
Senior Instructor, University of Manitoba
-
Adjunct Professor, Faculty of Environmental and Urban Change, York University, Canada
-
Professor, School of Rehabilitation Therapy, Queen's University, Ontario
-
Assistant Professor of Pharmacy, University of Waterloo
-
Research Coordinator, Centre for Health Services and Policy Research and School of Rehabilitation Therapy, Queen's University, Ontario
-
Canada Research Chair in Health Justice, University of Toronto
-
Professor, School of Population and Public Health, University of British Columbia
-
Professor, Political Science, McGill University
-
PhD Student, Political Science, L’Université d’Ottawa/University of Ottawa
-
Associate Professor, Johnson Shoyama Graduate School of Public Policy, University of Regina
-
PhD Candidate (Epidemiology), University of Toronto
